Research Studies

Clinical Trials

Effect of MS Therapy on Brain and Retinal Volume

Please contact Michael Devereux for more information.

Nerve Fiber Layer Analysis in Patients with Multiple Sclerosis, Optic Neuritis and Related Conditions

People with neurological disease as well as healthy controls may be eligible to participate.  Contact Nick Baker for more information.

Neurosarcoidosis

Neurological Manifestations of Sarcoidosis and Ways to Distinguish Sarcoidosis from other Causes of Nervous System Inflammation

Retinal Imaging to Diagnose and Track Neurodegenerative Disease

People with neurodegenerative disease as well as healthy controls may be eligible to participate.  Contact Nick Baker for further information.

Visual Evoked Potentials (VEP) in Neurological Disease

The purpose of this study is to determine how visual evoked potential testing, a non-invasive way to measure nerve function, correlates with neurological disease.  People with neurological disease as well as healthy controls may be eligible to participate.

OCTiMS

A 3-year, multi-center study to evaluate optical coherence tomography as an outcome measure in patients with multiple sclerosis.

Epic

The EPIC project (previously known as the GeneMSA study) is a unique and ambitious longitudinal study at UCSF that has followed 500 people with MS each year since 2004 with the purpose of capturing changes and learning factors that control the evolution of the disease.

ReCOVER

 A Randomized, Double-Blind, Parallel-Group, Placebo Controlled Trial to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis

 

ReBUILD **Closed to enrollment, results forthcoming**

A Randomized, Double-Blind, Parallel-Group, Placebo Controlled Crossover Trial to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of an Identified Small Molecule as a Remyelinating Agent in Multiple Sclerosis

Collaboratorive Scientists